NAIRO still apprehensive about safe use of HGH
Anti aging, Body Building, Buy hgh, Guide, HGH products, HGH: Human Growth Hormone, HgH, Hgh Effects, News, Review, Tips
NAIRO, trade association of independent review organizations (IROs) says that despite the fact that the HGH industry approaches $2 billion this year and it claims benefits for enhancing athletic performance, anti-aging and stimulating growth, it is regretted that many of these claims remain unproven.
“There’s much confusion about growth hormone therapy, even among healthcare professionals,” said Joyce Muller, NAIRO president. “Health plans wanting to determine the approved uses and standard of care for the drug should consult an IRO.”
This is the reason why FDA has strict laws against prescription of this drug. FDA has approved HGH for children to treat rare genetic conditions, such as Prader-Willi Syndrome (PWS) or Pituitary Dwarfism where it has shown therapeutic benefits, but again with the assistance of a pediatric endocrinologist.
The FDA approves HGH in adults only for relatively rare diseases–adult growth hormone deficiency and the wasting syndrome of late stage AIDS. In these treatments, after diagnosing patients with extensive blood tests doctors must monitor them closely.
“Health plans should be cautious about approving HGH therapies,” Muller said. “Because HGH carries sanctions for indications not approved by the FDA, health plans must consider the medical necessity of each case carefully to protect themselves, their providers, and their members. IROs can help them determine whether there’s a real medical need.”
Popularity: 1% [?]
 |
   |